Top compounds associated with response to ELF1


Feature Type Standardized
Nominal ANOVA
mRNA decitabine CTRPv2 pan-cancer AAC 0.3 2e-16
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.26 5e-12
mRNA CAL-101 CTRPv2 pan-cancer AAC 0.28 6e-09
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 1e-08
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.21 4e-08
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 5e-07
mRNA ibrutinib CTRPv2 pan-cancer AAC 0.27 1e-06
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.22 1e-06
mRNA clofarabine CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA LY317615 GDSC1000 pan-cancer AAC 0.23 2e-06
Download CSV